[Candesartan Cilexetil (Atacand) induced prolonged severe cholestasis improved by extracorporeal albumin dialysis].
Sturm
Nathalie
N
Hilleret
Marie-Noëlle
MN
Dreyfus
Thierry
T
Barnoud
Didier
D
Leroy
Vincent
V
Zarski
Jean-Pierre
JP
D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D001713:Biphenyl Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D001781:Blood Component Removal / Q000379:methods; D002779:Cholestasis / Q000139:chemically induced* / Q000628:therapy*; D005112:Extracorporeal Circulation; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012709:Serum Albumin; D013777:Tetrazoles / Q000008:administration & dosage / Q000009:adverse effects*
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D012709:Serum Albumin; D013777:Tetrazoles; C077793:candesartan cilexetil